Cytrx Corp (NASDAQ:CYTR)

CAPS Rating: 2 out of 5

A biopharmaceutical research and development company engaged in developing human therapeutic products based primarily upon its small molecule molecular chaperone co-induction technology.

Recs

0
Player Avatar markacutshall (< 20) Submitted: 2/22/2007 9:34:26 AM : Outperform Start Price: $30.07 CYTR Score: -84.45

This company has money in the bank out the wazoo and 0 debt. How can anyone not see that there has to be growth there?

Featured Broker Partners


Advertisement